Home> Products> dipeptidyl peptidase 4 inhibitor therapy

{ "products": [ { "_id": "68b02393f5434d48fca8b8ca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 50", "description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2165, "imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:38:27.036Z", "updatedon": "2025-08-28T09:38:27.036Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 50 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH LINA 25/5", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-08-04T12:40:52.619Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin and Linagliptin Tablets", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662aa04db100e1fdc2dcb68", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE 100 ", "description": "VILDIABATE 100 \nVildagliptin (100mg)\nVILDIABATE 100 is a medication designed to manage type 2 diabetes mellitus by targeting specific aspects of glucose regulation. It contains Vildagliptin, an oral antidiabetic agent that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Vildagliptin works by inhibiting the enzyme DPP-4, which is responsible for degrading incretin hormones like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).\n\nHere are key points about VILDIABATE 100:\n\nMechanism of Action: Vildagliptin acts by inhibiting DPP-4, thereby increasing the levels of GLP-1 and GIP. These hormones play crucial roles in glucose metabolism:\n\nGLP-1 stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner. It also inhibits glucagon secretion, reduces appetite, and slows gastric emptying.\nGIP enhances insulin release in response to meals, contributing to postprandial glucose control.\nBlood Sugar Control: By enhancing insulin secretion and reducing glucagon levels, VILDIABATE 100 helps lower blood sugar levels, especially after meals. This mechanism targets both fasting and postprandial hyperglycemia, contributing to overall glycemic control.\n\nDosage and Administration: VILDIABATE 100 is typically taken orally once daily, preferably with a meal to maximize its effects on postprandial glucose levels. The dosage may vary depending on individual needs and response to treatment. It's essential to follow your healthcare provider's instructions regarding dosage and timing.\n\nEfficacy and Safety: Clinical studies have demonstrated the efficacy of Vildagliptin in lowering HbA1c levels (a marker of long-term glucose control) and improving glycemic parameters. It is generally well-tolerated, with common side effects including headache, nasopharyngitis (inflammation of the nose and throat), and upper respiratory tract infections. Serious side effects are rare but may include pancreatitis or hypersensitivity reactions.\n\nCombination Therapy: VILDIABATE 100 may be prescribed as monotherapy or in combination with other antidiabetic medications such as metformin or sulfonylureas. Combining medications with different mechanisms of action can provide synergistic benefits in managing diabetes.\n\nMonitoring and Follow-Up: Regular monitoring of blood sugar levels, kidney function, and other relevant parameters is important during treatment with VILDIABATE 100. Your healthcare provider may adjust the dosage or add/modify other medications based on your response and individual needs.\n\nLifestyle Modifications: In addition to medication, lifestyle modifications such as a healthy diet, regular exercise, weight management, and avoiding tobacco and excessive alcohol intake are essential components of diabetes management.\n\nIn conclusion, VILDIABATE 100 containing Vildagliptin is an effective oral antidiabetic medication that helps regulate blood sugar levels in patients with type 2 diabetes. It acts by enhancing insulin secretion and reducing postprandial glucose levels, contributing to improved glycemic control. However, it should be used under medical supervision, and adherence to prescribed dosage and lifestyle recommendations is crucial for optimal diabetes management.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452\n\n\n\n\n\n", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "nose", "GLP-1", "EMAIL", "class", "meals", "Order", "timing", "throat", "enzyme", "Safety", "Dosage", "marker", "tobacco", "fasting", "response", "addition", "appetite", "headache", "patients", "Efficacy", "metformin", "Follow-Up", "adherence", "treatment", "VILDIABATE", "conclusion", "key points", "information", "monotherapy", "healthy diet", "instructions", "sterisonline", "pancreatitis", "inflammation", "sterispharma", "HbA1c levels", "CALL/WHATSAPP", "sulfonylureas", "crucial roles", "Administration", "insulin release", "nasopharyngitis", "kidney function", "glucagon levels", "gastric emptying", "specific aspects", "Clinical studies", "individual needs", "regular exercise", "other medications", "Vildagliptin acts", "incretin hormones", "DPP-4) inhibitors", "weight management", "insulin secretion", "glucose metabolism", "glucose regulation", "glucagon secretion", "blood sugar levels", "Regular monitoring", "Combination Therapy", "glycemic parameters", "common side effects", "Blood Sugar Control", "medical supervision", "healthcare provider", "essential components", "synergistic benefits", "different mechanisms", "Serious side effects", "pancreatic beta cells", "dipeptidyl peptidase-4", "oral antidiabetic agent", "Lifestyle Modifications", "glucose-dependent manner", "excessive alcohol intake", "overall glycemic control", "type 2 diabetes mellitus", "lifestyle recommendations", "other relevant parameters", "long-term glucose control", "hypersensitivity reactions", "postprandial hyperglycemia", "optimal diabetes management", "postprandial glucose levels", "postprandial glucose control", "other antidiabetic medications", "upper respiratory tract infections", "effective oral antidiabetic medication", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1491, "imageuri": "https://productimages.withfloats.com/actual/6662aa0b364f23242470b3ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662aa0b364f23242470b3ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:34:44.056Z", "updatedon": "2024-06-28T11:58:50.164Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1491", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE 100 ", "category": "DIABETIC RANGE", "tags": [ "VILDIABATE 100", "Vildagliptin (100mg)", "Vildagliptin 100 mg uses", "Vildagliptin 100 mg price", "Vildagliptin 100 mg SR brand Name", "Vildagliptin 100 mg brands in India", "", "Vildagliptin 100 mg generic medicine", "Vildagliptin 100 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666050a6ea22b014e8af196f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP M 5/500 ", "description": "LINALIGLIP M 5/500 \nLinagliptin 5mg and Metformin Hydrochloride (SR) 500mg\nIntroduction to LINALIGLIP M 5/500\nLINALIGLIP M 5/500 is a combination medication that includes Linagliptin 5mg and Metformin Hydrochloride (Sustained Release) 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Linagliptin and Metformin, LINALIGLIP M 5/500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Linagliptin and Metformin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release (SR) formulation ensures a prolonged effect throughout the day.\n\nBenefits of LINALIGLIP M 5/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Linagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP M 5/500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP M 5/500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is known to have a neutral or weight-reducing effect, making it beneficial for patients concerned about weight gain.\nCardiovascular Protection: The combination may offer additional cardiovascular benefits by improving overall metabolic health.\nConvenience and Compliance\nTwice-Daily Dosing: The sustained-release formulation of Metformin allows for effective blood sugar control with twice-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use LINALIGLIP M 5/500\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP M 5/500 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP M 5/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-m-5-500-134301", "price": 245.0, "discountamount": 73.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "Order", "EMAIL", "liver", "meals", "water", "amount", "action", "neutral", "Support", "Overview", "patients", "one pill", "readings", "biguanide", "Guidelines", "full glass", "one tablet", "neuropathy", "Optimal Use", "utilization", "retinopathy", "Convenience", "Adjustments", "information", "weight gain", "Introduction", "Reduced Risk", "best results", "sterispharma", "Postprandial", "sterisonline", "CALL/WHATSAPP", "effectiveness", "typical dosage", "dual mechanism", "Administration", "treatment plan", "Consistent Use", "insulin release", "Linagliptin 5mg", "glucagon levels", "two medications", "prolonged effect", "Exercise Adjunct", "incretin hormones", "Weight Management", "Sustained Release", "treatment regimen", "excellent adjunct", "multiple pathways", "LINALIGLIP M 5/500", "glucose regulation", "patient compliance", "Twice-Daily Dosing", "Recommended Dosage", "prescribed therapy", "individual response", "insulin sensitivity", "Reduced Pill Burden", "Diabetes Management", "healthcare provider", "meal) glucose levels", "blood glucose levels", "cardiovascular disease", "combination medication", "weight-reducing effect", "Fasting Glucose Control", "lifestyle modifications", "Metformin Hydrochloride", "long-term complications", "complementary mechanisms", "type 2 diabetes mellitus", "overall metabolic health", "Cardiovascular Protection", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "hepatic glucose production", "overall blood sugar control", "gastrointestinal discomfort", "sustained-release formulation", "effective blood sugar control", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "additional cardiovascular benefits", "sustained-release (SR) formulation", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1384, "imageuri": "https://productimages.withfloats.com/actual/666050a84f159c14e162c5d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/666050a84f159c14e162c5d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:48:54.497Z", "updatedon": "2024-06-29T11:16:30.61Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/linaliglip-m-5-500-/1384", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP M 5/500 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP M 5/500", "Linagliptin 5mg", "Metformin Hydrochloride (SR) 500mg", "Metformin hydrochloride SR 500 mg uses", "Metformin SR 500 side effects", "Metformin SR 500 dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604fa8870e7b20c49e43ef", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP 2.5/500 ", "description": "LINALIGLIP 2.5/500 \nLinagliptin & Metformin Hydrochloride\nIntroduction to LINALIGLIP 2.5/500\nLINALIGLIP 2.5/500 is a combination medication that includes Linagliptin 2.5mg and Metformin Hydrochloride 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Linagliptin and Metformin, LINALIGLIP 2.5/500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Linagliptin and Metformin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of LINALIGLIP 2.5/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Linagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP 2.5/500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP 2.5/500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nTwice-Daily Dosing: The formulation allows for effective blood sugar control with twice-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use LINALIGLIP 2.5/500\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP 2.5/500 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP 2.5/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-2-5-500-134273", "price": 255.0, "discountamount": 76.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "water", "liver", "EMAIL", "meals", "Order", "action", "amount", "therapy", "Support", "readings", "Benefits", "Overview", "one pill", "patients", "biguanide", "one tablet", "Guidelines", "neuropathy", "full glass", "retinopathy", "Convenience", "formulation", "Adjustments", "Linagliptin", "information", "Optimal Use", "utilization", "Reduced Risk", "best results", "sterisonline", "Introduction", "Postprandial", "sterispharma", "CALL/WHATSAPP", "effectiveness", "Administration", "typical dosage", "Consistent Use", "treatment plan", "dual mechanism", "glucagon levels", "two medications", "insulin release", "Exercise Adjunct", "treatment regimen", "multiple pathways", "excellent adjunct", "incretin hormones", "patient compliance", "LINALIGLIP 2.5/500", "glucose regulation", "Twice-Daily Dosing", "Recommended Dosage", "Diabetes Management", "healthcare provider", "Reduced Pill Burden", "individual response", "insulin sensitivity", "meal) glucose levels", "blood glucose levels", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "Metformin Hydrochloride", "Fasting Glucose Control", "complementary mechanisms", "type 2 diabetes mellitus", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "gastrointestinal discomfort", "overall blood sugar control", "effective blood sugar control", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1382, "imageuri": "https://productimages.withfloats.com/actual/66604fab4f159c14e162bd89.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604fab4f159c14e162bd89.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:44:40.743Z", "updatedon": "2024-06-29T11:20:20.557Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/linaliglip-2-5-500-/1382", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP 2.5/500 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP 2.5/500", "Linagliptin", "Metformin Hydrochloride", "Metformin hydrochloride uses", "Metformin hydrochloride side effects", "Metformin hydrochloride used for", "metformin hydrochloride dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604d847b387b17ecbcdf32", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP 5 ", "description": "LINALIGLIP 5 \nLinagliptin (5mg)\nIntroduction to LINALIGLIP 5\nLINALIGLIP 5 contains Linagliptin 5mg, a medication used primarily for the management of type 2 diabetes mellitus. Linagliptin belongs to a class of drugs known as DPP-4 (dipeptidyl peptidase-4) inhibitors, which help improve blood sugar control by enhancing the body's natural incretin hormones. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Linagliptin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nMechanism of Action\nDPP-4 Inhibition: Linagliptin works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. By inhibiting this enzyme, Linagliptin increases the levels of incretin hormones, which stimulate insulin release and decrease glucagon production in response to meals.\nEnhanced Insulin Response: The increased insulin release helps lower postprandial (after-meal) blood sugar levels, while decreased glucagon levels reduce hepatic glucose production, contributing to overall blood sugar control.\nBenefits of LINALIGLIP 5\nEffective Blood Sugar Management\nPostprandial Glucose Control: LINALIGLIP 5 helps reduce blood sugar spikes after meals by enhancing the body's natural insulin response.\nOverall Glycemic Control: By increasing incretin hormones, Linagliptin helps maintain stable blood glucose levels throughout the day, providing comprehensive glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP 5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP 5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nOnce-Daily Dosing: LINALIGLIP 5 is taken once daily, making it convenient for patients to incorporate into their daily routine.\nComplementary Therapy: Linagliptin can be used as monotherapy or in combination with other antidiabetic medications for a more comprehensive diabetes management plan.\nHow to Use LINALIGLIP 5\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP 5 is one 5mg tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. It is important to take the medication at the same time each day to maintain consistent blood levels.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP 5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-5-134269", "price": 225.0, "discountamount": 67.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "diet", "food", "EMAIL", "class", "drugs", "water", "meals", "Order", "enzyme", "Action", "adults", "Dosing", "Support", "Overview", "patients", "readings", "Benefits", "Mechanism", "same time", "Compliance", "Guidelines", "full glass", "neuropathy", "LINALIGLIP", "Optimal Use", "Convenience", "information", "retinopathy", "Adjustments", "combination", "monotherapy", "Introduction", "Reduced Risk", "sterisonline", "best results", "sterispharma", "CALL/WHATSAPP", "daily routine", "typical dosage", "Administration", "one 5mg tablet", "treatment plan", "Consistent Use", "insulin release", "Linagliptin 5mg", "glucagon levels", "DPP-4 inhibitor", "DPP-4 Inhibition", "Exercise Adjunct", "excellent adjunct", "blood sugar spikes", "Recommended Dosage", "healthcare provider", "glucagon production", "individual response", "Complementary Therapy", "cardiovascular disease", "long-term complications", "lifestyle modifications", "consistent blood levels", "natural insulin response", "Overall Glycemic Control", "meal) blood sugar levels", "type 2 diabetes mellitus", "natural incretin hormones", "Enhanced Insulin Response", "stable blood sugar levels", "hepatic glucose production", "stable blood glucose levels", "overall blood sugar control", "Postprandial Glucose Control", "other antidiabetic medications", "comprehensive glycemic control", "Effective Blood Sugar Management", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1378, "imageuri": "https://productimages.withfloats.com/actual/66604d874f159c14e162a2e5.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604d874f159c14e162a2e5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:35:32.901Z", "updatedon": "2024-06-29T11:41:40.984Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/linaliglip-5-/1378", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP 5 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP 5", "Linagliptin (5mg)", "Linagliptin 5mg side effects", "Linagliptin 5 mg price", "Linagliptin 5 mg price in India", "linagliptin 5 mg tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604a47870e7b20c49e422b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP 2.5 ", "description": "LINALIGLIP 2.5 \nLinagliptin 2.5 mg\nIntroduction to LINALIGLIP 2.5\nLINALIGLIP 2.5 contains Linagliptin 2.5mg, a medication used primarily for the management of type 2 diabetes mellitus. Linagliptin belongs to a class of drugs known as DPP-4 (dipeptidyl peptidase-4) inhibitors, which help improve blood sugar control by enhancing the body's natural incretin hormones. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Linagliptin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nMechanism of Action\nDPP-4 Inhibition: Linagliptin works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. By inhibiting this enzyme, Linagliptin increases the levels of incretin hormones, which stimulate insulin release and decrease glucagon production in response to meals.\nEnhanced Insulin Response: The increased insulin release helps lower postprandial (after-meal) blood sugar levels, while decreased glucagon levels reduce hepatic glucose production, contributing to overall blood sugar control.\nBenefits of LINALIGLIP 2.5\nEffective Blood Sugar Management\nPostprandial Glucose Control: LINALIGLIP 2.5 helps reduce blood sugar spikes after meals by enhancing the body's natural insulin response.\nOverall Glycemic Control: By increasing incretin hormones, Linagliptin helps maintain stable blood glucose levels throughout the day, providing comprehensive glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP 2.5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP 2.5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nOnce-Daily Dosing: LINALIGLIP 2.5 is taken once daily, making it convenient for patients to incorporate into their daily routine.\nComplementary Therapy: Linagliptin can be used as monotherapy or in combination with other antidiabetic medications for a more comprehensive diabetes management plan.\nHow to Use LINALIGLIP 2.5\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP 2.5 is one 2.5mg tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. It is important to take the medication at the same time each day to maintain consistent blood levels.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP 2.5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-2-5-134280", "price": 205.0, "discountamount": 61.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "diet", "food", "Order", "class", "EMAIL", "drugs", "water", "meals", "adults", "Dosing", "Action", "enzyme", "Support", "Overview", "Benefits", "patients", "readings", "Mechanism", "same time", "LINALIGLIP", "neuropathy", "Compliance", "full glass", "Guidelines", "Optimal Use", "information", "combination", "monotherapy", "Convenience", "retinopathy", "Adjustments", "sterispharma", "Introduction", "Reduced Risk", "sterisonline", "best results", "daily routine", "CALL/WHATSAPP", "Administration", "typical dosage", "treatment plan", "Consistent Use", "glucagon levels", "insulin release", "DPP-4 inhibitor", "one 2.5mg tablet", "DPP-4 Inhibition", "Exercise Adjunct", "excellent adjunct", "Linagliptin 2.5mg", "blood sugar spikes", "Recommended Dosage", "healthcare provider", "glucagon production", "individual response", "Complementary Therapy", "cardiovascular disease", "lifestyle modifications", "long-term complications", "consistent blood levels", "Overall Glycemic Control", "natural insulin response", "type 2 diabetes mellitus", "meal) blood sugar levels", "natural incretin hormones", "stable blood sugar levels", "Enhanced Insulin Response", "hepatic glucose production", "stable blood glucose levels", "overall blood sugar control", "Postprandial Glucose Control", "other antidiabetic medications", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitors", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1376, "imageuri": "https://productimages.withfloats.com/actual/66604a496030c166b1a78a3e.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604a496030c166b1a78a3e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:21:43.142Z", "updatedon": "2024-06-29T12:00:41.066Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//linaliglip-2-5-/1376", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP 2.5 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP 2.5", "Linagliptin 2.5 mg", "Linagliptin 2.5 mg uses", "Linagliptin 2.5 mg side effects", "Linagliptin 2.5 mg price", "Linagliptin 2.5 mg price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6660456866170d1ff8cb29b0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLISITAPTIN M KIT ", "description": "GLISITAPTIN M KIT \nCombipack of sitagliptin phosphate (100mg) & Metformin HCI SR (1000mg)\nIntroduction to GLISITAPTIN M KIT\nGLISITAPTIN M KIT is a combination pack that includes Sitagliptin Phosphate 100mg and Metformin HCl SR 1000mg. This combipack is designed for the comprehensive management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, GLISITAPTIN M KIT provides effective glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release (SR) formulation ensures a prolonged effect throughout the day.\n\nBenefits of GLISITAPTIN M KIT\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Sitagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: GLISITAPTIN M KIT is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, this combination medication can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nTwice-Daily Dosing: The sustained-release formulation of Metformin allows for effective blood sugar control with twice-daily dosing, improving patient compliance.\nReduced Pill Burden: Combining two effective diabetes medications into a single combipack simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use GLISITAPTIN M KIT\nDosage and Administration\nRecommended Dosage: The typical dosage of GLISITAPTIN M KIT is one tablet of Sitagliptin 100mg taken once daily and one tablet of Metformin HCl SR 1000mg taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablets with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablets whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLISITAPTIN M KIT regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glisitaptin-m-kit-133870", "price": 555.0, "discountamount": 166.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "Order", "EMAIL", "meals", "liver", "water", "amount", "action", "Support", "tablets", "patients", "Overview", "Benefits", "readings", "biguanide", "neuropathy", "one tablet", "Guidelines", "full glass", "retinopathy", "information", "Optimal Use", "Convenience", "utilization", "Adjustments", "best results", "Postprandial", "sterispharma", "Introduction", "Reduced Risk", "sterisonline", "blood glucose", "CALL/WHATSAPP", "effectiveness", "Administration", "typical dosage", "Consistent Use", "dual mechanism", "treatment plan", "glucagon levels", "two medications", "insulin release", "Metformin HCl SR", "Metformin HCI SR", "Exercise Adjunct", "prolonged effect", "combination pack", "single combipack", "Sitagliptin 100mg", "multiple pathways", "excellent adjunct", "GLISITAPTIN M KIT", "treatment regimen", "glucose regulation", "Twice-Daily Dosing", "patient compliance", "Recommended Dosage", "prescribed therapy", "Reduced Pill Burden", "insulin sensitivity", "individual response", "healthcare provider", "Diabetes Management", "meal) glucose levels", "sitagliptin phosphate", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "comprehensive management", "type 2 diabetes mellitus", "complementary mechanisms", "natural incretin hormones", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "effective glycemic control", "gastrointestinal discomfort", "sustained-release formulation", "effective blood sugar control", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "two effective diabetes medications", "sustained-release (SR) formulation", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1373, "imageuri": "https://productimages.withfloats.com/actual/6660456a9a0a3c2c06ff4c20.png", "tileimageuri": "https://productimages.withfloats.com/tile/6660456a9a0a3c2c06ff4c20.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:00:56.265Z", "updatedon": "2024-06-29T12:05:00.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glisitaptin-m-kit-/1373", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN M KIT ", "category": "DIABETIC RANGE", "tags": [ "GLISITAPTIN M KIT", "Combipack of sitagliptin phosphate (100mg)", "Metformin HCI SR (1000mg)", "Metformin SR 1000 mg uses", "Metformin SR 1000 mg side effects", "Metformin SR 1000 Mg Uses in Hindi", "Metformin SR 1000 mg price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }